Abbott And AbbVie To Present At Financial Conferences
ABBOTT PARK, Ill., Dec. 21, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) and AbbVie will present at financial conferences in January 2013.
Abbott will present at the 31 st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2013. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at noon Central time.
AbbVie will present at the Goldman Sachs Healthcare CEOs Unscripted conference on Thursday, Jan. 3, 2013. Richard A. Gonzalez, chairman and chief executive officer, will participate in a question and answer session at 9:15 a.m. Central time.
AbbVie will also present at the 31 st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2013. Bill Chase, executive vice president and chief financial officer, will make a formal presentation on the company at 5:30 p.m. Central time.
A live audio webcast of the Abbott and AbbVie presentations will be accessible on the presentation day through each company's respective Investor Relations website: www.abbottinvestor.com and www.abbvieinvestor.com. An archived edition of the presentations will also be available later that day on each website. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com.SOURCE Abbott
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
